These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32958331)

  • 1. Prenatal opioid exposure - Increasing evidence of harm.
    Mactier H; Hamilton R
    Early Hum Dev; 2020 Nov; 150():105188. PubMed ID: 32958331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids affect the fetal brain: reframing the detoxification debate.
    Caritis SN; Panigrahy A
    Am J Obstet Gynecol; 2019 Dec; 221(6):602-608. PubMed ID: 31323217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.
    Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L
    Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal exposure to methadone or buprenorphine and long-term outcomes: A meta-analysis.
    Andersen JM; Høiseth G; Nygaard E
    Early Hum Dev; 2020 Apr; 143():104997. PubMed ID: 32146140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal Risk Factors and Perinatal and Postnatal Outcomes Associated With Maternal Opioid Exposure in an Urban, Low-Income, Multiethnic US Population.
    Azuine RE; Ji Y; Chang HY; Kim Y; Ji H; DiBari J; Hong X; Wang G; Singh GK; Pearson C; Zuckerman B; Surkan PJ; Wang X
    JAMA Netw Open; 2019 Jun; 2(6):e196405. PubMed ID: 31251378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired vision in children prenatally exposed to methadone: an observational cohort study.
    Hamilton R; Mulvihill A; Butler L; Chow A; Irving E; McCulloch DL; McNeil A; Michael K; Spowart KM; Waterson-Wilson J; Mactier H
    Eye (Lond); 2024 Jan; 38(1):118-126. PubMed ID: 37402864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborns exposed to opioids need mothers more than NICU, say pediatricians.
    Vogel L
    CMAJ; 2018 Jan; 190(4):E123-E124. PubMed ID: 29378878
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
    Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
    Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal and longer term management following substance misuse in pregnancy.
    Mactier H
    Early Hum Dev; 2013 Nov; 89(11):887-92. PubMed ID: 24113212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal Opioid Exposure and Neurodevelopmental Outcomes.
    Lee JJ; Saraiya N; Kuzniewicz MW
    J Neurosurg Anesthesiol; 2023 Jan; 35(1):142-146. PubMed ID: 36745179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome reporting in neonates experiencing withdrawal following opioid exposure in pregnancy: a systematic review.
    Shan F; MacVicar S; Allegaert K; Offringa M; Jansson LM; Simpson S; Moulsdale W; Kelly LE
    Trials; 2020 Mar; 21(1):262. PubMed ID: 32164782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors Associated with the Occurrence of Neonatal Opioid Withdrawal Syndrome: A Review.
    Kelty E; Preen DB
    CNS Drugs; 2019 Nov; 33(11):1113-1120. PubMed ID: 31686408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal Opioid Exposure, Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome, and Later Child Development Research: Shortcomings and Solutions.
    Jones HE; Kaltenbach K; Benjamin T; Wachman EM; O'Grady KE
    J Addict Med; 2019; 13(2):90-92. PubMed ID: 30334926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.
    Dave CV; Goodin A; Zhu Y; Winterstein A; Wang X; Alrwisan A; Hartzema A
    Pharmacotherapy; 2019 Oct; 39(10):1005-1011. PubMed ID: 31361913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal abstinence syndrome.
    Coyle MG; Brogly SB; Ahmed MS; Patrick SW; Jones HE
    Nat Rev Dis Primers; 2018 Nov; 4(1):47. PubMed ID: 30467370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal Abstinence Syndrome: Review of Epidemiology, Care Models, and Current Understanding of Outcomes.
    MacMillan KDL
    Clin Perinatol; 2019 Dec; 46(4):817-832. PubMed ID: 31653310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal Opioid Exposure and Immune-Related Conditions in Children.
    Kelty E; Rae K; Jantzie LL; Wyrwoll CS; Preen DB
    JAMA Netw Open; 2024 Jan; 7(1):e2351933. PubMed ID: 38231512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
    Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
    Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome.
    Maguire DJ; Taylor S; Armstrong K; Shaffer-Hudkins E; Germain AM; Brooks SS; Cline GJ; Clark L
    Neonatal Netw; 2016; 35(5):277-86. PubMed ID: 27636691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal opioid withdrawal syndrome.
    Sutter MB; Leeman L; Hsi A
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):317-34. PubMed ID: 24845493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.